Primary Site >> Liver Cancer

Gene >> TFCP2

Journal: Proc Natl Acad Sci U S A. 2010 May 4;107(18):8357-62.
Title: Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma.
Author: Yoo, Byoung Kwon|Emdad, Luni|Gredler, Rachel|Fuller, Christine|Dumur, Catherine I|Jones, Kimberly H|Jackson-Cook, Colleen|Su, Zao-Zhong|Chen, Dong|Saxena, Utsav H|Hansen, Ulla|Fisher, Paul B|Sarkar, Devanand
PMID: 20404171
Journal: J Hepatol. 2011 Dec;55(6):1317-24.
Title: c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF.
Author: Yoo, Byoung Kwon|Gredler, Rachel|Chen, Dong|Santhekadur, Prasanna K|Fisher, Paul B|Sarkar, Devanand
PMID: 21703197
Journal: World J Gastroenterol. 2011 Aug 7;17(29):3420-30.
Title: Late SV40 factor: a key mediator of Notch signaling in human hepatocarcinogenesis.
Author: Fan, Ren-Hua|Li, Jing|Wu, Nan|Chen, Ping-Sheng
PMID: 21876634
Journal: J Mol Histol. 2011 Oct;42(5):473-81.
Title: Cooperation of deregulated Notch signaling and Ras pathway in human hepatocarcinogenesis.
Author: Fan, Renhua|Chen, Pingsheng|Zhao, Di|Tong, Jing Long|Li, Jing|Liu, Feng
PMID: 21892768
Journal: J Biol Chem. 2012 Jan 27;287(5):3425-32.
Title: Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9).
Author: Santhekadur, Prasanna K|Gredler, Rachel|Chen, Dong|Siddiq, Ayesha|Shen, Xue-Ning|Das, Swadesh K|Emdad, Luni|Fisher, Paul B|Sarkar, Devanand
PMID: 22167195
Journal: Am J Cancer Res. 2012;2(3):269-85. Epub 2012 Apr 21.
Title: The transcription factor LSF: a novel oncogene for hepatocellular carcinoma.
Author: Santhekadur, Prasanna K|Rajasekaran, Devaraja|Siddiq, Ayesha|Gredler, Rachel|Chen, Dong|Schaus, Scott E|Hansen, Ulla|Fisher, Paul B|Sarkar, Devanand
PMID: 22679558
Journal: World J Gastroenterol. 2012 Dec 14;18(46):6709-11.
Title: Targeting late SV40 factor: is the achilles heel of hepatocarcinogenesis revealed?
Author: Shlomai, Amir
PMID: 23239907
Journal: Radiology. 2014 May;271(2):602-12.
Title: Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting.
Author: Gaba, Ron C|Zivin, Sean P|Dikopf, Mark S|Parvinian, Ahmad|Casadaban, Leigh C|Lu, Yang|Bui, James T
PMID: 24533871
Journal: Pediatr Blood Cancer. 2014 Aug;61(8):1350-6.
Title: Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.
Author: Martin, Alissa|Schneiderman, Jennifer|Helenowski, Irene B|Morgan, Elaine|Dilley, Kimberley|Danner-Koptik, Karina|Hatahet, Mohamad|Shimada, Hiroyuki|Cohn, Susan L|Kletzel, Morris|Hijiya, Nobuko
PMID: 24634399
Journal: J Exp Clin Cancer Res. 2015 Jan 22;34:6.
Title: Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis.
Author: Xu, Xiao|Liu, Zhikun|Zhou, Lin|Xie, Haiyang|Cheng, Jun|Ling, Qi|Wang, Jianguo|Guo, Haijun|Wei, Xuyong|Zheng, Shusen
PMID: 25609232
Journal: Oncotarget. 2015 Oct 20;6(32):33658-74.
Title: GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS axis in hepatocellular carcinoma.
Author: Gu, Yan-jiao|Li, Hong-dan|Zhao, Liang|Zhao, Song|He, Wu-bin|Rui, Li|Su, Chang|Zheng, Hua-chuan|Su, Rong-jian
PMID: 26378040
Journal: Oncotarget. 2015 Sep 22;6(28):26266-77.
Title: Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model.
Author: Rajasekaran, Devaraja|Siddiq, Ayesha|Willoughby, Jennifer L S|Biagi, Jessica M|Christadore, Lisa M|Yunes, Sarah A|Gredler, Rachel|Jariwala, Nidhi|Robertson, Chadia L|Akiel, Maaged A|Shen, Xue-Ning|Subler, Mark A|Windle, Jolene J|Schaus, Scott E|Fisher, Pa
PMID: 26313006
Journal: Clin Nucl Med. 2016 Jan;41(1):21-7.
Title: 90Y Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival.
Author: Xing, Minzhi|Lahti, Steven|Kokabi, Nima|Schuster, David M|Camacho, Juan C|Kim, Hyun S
PMID: 26222534
Journal: Oncotarget. 2016 Jan 19;7(3):2379-90.
Title: Transcription factor LSF (TFCP2) inhibits melanoma growth.
Author: Goto, Yuji|Yajima, Ichiro|Kumasaka, Mayuko|Ohgami, Nobutaka|Tanaka, Asami|Tsuzuki, Toyonori|Inoue, Yuji|Fukushima, Satoshi|Ihn, Hironobu|Kyoya, Mikiko|Ohashi, Hiroyuki|Kawakami, Tamihiro|Bennett, Dorothy C|Kato, Masashi
PMID: 26506241
Journal: J Vasc Interv Radiol. 2016 Jun;27(6):804-11.
Title: Elevated Lung Shunt Fraction as a Prognostic Indicator for Disease Progression and Metastasis in Hepatocellular Carcinoma.
Author: Sandow, Tyler|DeVun, Daniel|Gulotta, Paul|Bohorquez, Humberto|Kirsch, David
PMID: 27009570
Journal: Oncotarget. 2016 Dec 13;7(50):83627-83640.
Title: Transcription factor LSF-DNMT1 complex dissociation by FQI1 leads to aberrant DNA methylation and gene expression.
Author: Chin, Hang Gyeong|Ponnaluri, V K Chaithanya|Zhang, Guoqiang|Esteve, Pierre-Olivier|Schaus, Scott E|Hansen, Ulla|Pradhan, Sriharsa
PMID: 27845898
Journal: Gastroenterol Res Pract. 2017;2017:6353248.
Title: TFCP2 Genetic Polymorphism Is Associated with Predisposition to and Transplant Prognosis of Hepatocellular Carcinoma.
Author: Liu, Zhikun|Gao, Feng|Shao, Zhou|Xie, Haiyang|Zhou, Lin|Xu, Xiao|Zheng, Shusen
PMID: 28348581
Journal: Cell Rep. 2017 Oct 31;21(5):1227-1239.
Title: TFCP2 Is Required for YAP-Dependent Transcription to Stimulate Liver Malignancy.
Author: Zhang, Xiao|Sun, Fenyong|Qiao, Yongxia|Zheng, Weisheng|Liu, Ya|Chen, Yan|Wu, Qi|Liu, Xiangfan|Zhu, Guoqing|Chen, Yuxin|Yu, Yongchun|Pan, Qiuhui|Wang, Jiayi
PMID: 29091762
Journal: Cancer Lett. 2018 Apr 28;420:72-79.
Title: TFCP2/TFCP2L1/UBP1 transcription factors in cancer.
Author: Kotarba, Grzegorz|Krzywinska, Ewa|Grabowska, Anna I|Taracha, Agnieszka|Wilanowski, Tomasz
PMID: 29410248